Güresir Ági, Coch Christoph, Heine Annkristin, Mass Elvira, Lampmann Tim, Vatter Hartmut, Velten Markus, Schmitz Marie-Therese, Güresir Erdem, Wach Johannes
Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.
Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Front Neurol. 2022 May 11;13:884231. doi: 10.3389/fneur.2022.884231. eCollection 2022.
Recent studies have demonstrated emerging evidence of the role of inflammation in the growth and recurrence of chronic subdural hematoma (cSDH). Red blood cell distribution width to platelet count ratio (RPR) is a novel biomarker for inflammation in cancer, cardiac, and inflammatory diseases. The present retrospective study investigated the impact of RPR on recurrence after burr hole surgery for cSDH in 297 patients.
The optimal cut-off value for RPR was defined as ≥0.0568 according to the receiver operating characteristic curve (AUC:0.64, 95%CI:0.55-0.72, = 0.007). The study cohort was dichotomized into low ( = 157) and high ( = 140) RPR groups.
Significant differences between the groups were identified regarding American Society of Anesthesiologists (ASA) classification and frequency of anticoagulant intake. Demographics, comorbidities, size, morphology, and mass effect of cSDH were homogeneously distributed among the RPR groups. Multivariable binary logistic regression analysis considering location, midline-shift, septation, RPR, anticoagulant intake, sex, and ASA classification revealed that an increased baseline RPR (≥0.0568, OR: 3.1, 95%CI: 1.4-6.8, = 0.004), and preoperative midline-shift (≥5 mm, OR: 2.7, 95%CI: 1.3-6.0, = 0.01) are independent predictors of recurrent cSDH.
The present findings suggest RPR as a novel inflammatory biomarker enabling risk stratification of recurrence after burr hole surgery for cSDH and might facilitate tailored medical decision making.
近期研究已证明炎症在慢性硬膜下血肿(cSDH)生长和复发中的作用有了新的证据。红细胞分布宽度与血小板计数比值(RPR)是癌症、心脏疾病及炎症性疾病中炎症的一种新型生物标志物。本回顾性研究调查了RPR对297例接受cSDH钻孔手术患者术后复发的影响。
根据受试者工作特征曲线,RPR的最佳截断值定义为≥0.0568(曲线下面积:0.64,95%置信区间:0.55 - 0.72,P = 0.007)。研究队列被分为低RPR组(n = 157)和高RPR组(n = 140)。
在麻醉医师协会(ASA)分级和抗凝剂使用频率方面,两组之间存在显著差异。cSDH的人口统计学、合并症、大小、形态及占位效应在RPR组间分布均匀。多变量二元逻辑回归分析考虑了位置、中线移位、分隔、RPR、抗凝剂使用、性别和ASA分级,结果显示基线RPR升高(≥0.0568,比值比:3.1,95%置信区间:1.4 - 6.8,P = 0.004)以及术前中线移位(≥5 mm,比值比:2.7,95%置信区间:1.3 - 6.0,P = 0.01)是复发性cSDH的独立预测因素。
本研究结果表明RPR是一种新型炎症生物标志物,能够对cSDH钻孔手术后复发进行风险分层,并可能有助于制定个性化的医疗决策。